Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 549-557

  Hussein Al Ali, Samer Hasan ^a   El Zowalaty, Mohamed Ezzat ^a,c   Hussein, Mohd Zobir ^a   Ismail, Maznah ^a   Webster, Thomas J ^b,d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Northeastern University   (United States)

^c JAZAN UNIVERSITY   (Saudi Arabia)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobial activity; Chitosan; Magnetic nanoparticles; Methicillin resistant staphylococcus aureus; Nanoantibiotics; Release; Streptomycin

Indexed keywords

CHITOSAN; MAGNETIC NANOPARTICLE; NANOCOMPOSITE; STREPTOMYCIN; STREPTOMYCIN LOADED CHITOSAN MAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; MAGNETITE NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MAGNETOMETRY; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; X RAY DIFFRACTION; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; NANOMEDICINE; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; CHITOSAN; DELAYED-ACTION PREPARATIONS; HUMANS; MAGNETITE NANOPARTICLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NANOCOMPOSITES; NANOMEDICINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STREPTOMYCIN; X-RAY DIFFRACTION;

EID: 84892586300     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S53079     Document Type: Article

References (38)

1. Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. NanoBioscience. 2004;3:66-73.
2. Tran N, Webster TJ. Magnetic nanoparticles: biomedical applications and challenges. J Mater Chem. 2010;20:8760-8767.
3. Sun S, Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc. 2002;124:8204-8205.
4. Jones N, Ray B, Ranjit KT, Manna AC. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett. 2008;279:71-76.
5. Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 2013;4:1457-1465.
6. Raafat D, Von Bargen K, Haas A, Sahl H-G. Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol. 2008;74:3764-3773.
7. Eckhardt S, Brunetto PS, Gagnon J, Priebe M, Giese B, Fromm KM. Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. Chem Rev. 2013:4708-4754.
8. Mahmoudi M, Serpooshan V. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano. 2012;6:2656-2664.
9. Schatz A, Waksman SA. Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. In: Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. New York, NY: Royal Society of Medicine; 1944.
10. Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004;169:1181-1186.
11. Schatz A, Bugle E, Waksman SA. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. In: Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. New York, NY: Royal Society of Medicine; 1944.
12. Ramirez MS, Nikolaidis N, Tolmasky ME. Rise and dissemination of aminoglycoside resistance: the aac (6′)-Ib paradigm. Front Microbiol. 2013;4:121.
13. Becker B, Cooper MA. Aminoglycoside antibiotics in the 21st century. ACS Chem Biol. 2012;8:105-115.
14. Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc. 1991;66:1158-1164.
15. Kuznetsov AA, Filippov VI, Kuznetsov OA, Gerlivanov VG, Dobrinsky EK, Malashin SI. New ferro-carbon adsorbents for magnetically guided transport of anti-cancer drugs. J Magn Magn Mater. 1999;194:22-30.
16. Andrews JM. BSAC standardized disc susceptibility testing method. J Antimicrob Chemother. 2001;48 Suppl 1:43-57.
17. Silva SML, Braga CRC, Fook MVL, Raposo CMO, Carvalho LH, Canedo EL. Application of infrared spectroscopy to analysis of chitosan/clay nanocomposites. In: Theophanides T, editor. Infrared Spectroscopy-Materials Science, Engineering and Technology; 2012. Available from: http://www.intechopen.com/books/infrared-spectroscopy-materials-science-engineering-andtechnology/application-of-infrared-spectroscopy-to-analysis-of-chitosan-clay-nanocomposites. Accessed October 3, 2013.
18. Qu JB, Shao HH, Jing GL, Huang F. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2013;102:37-44.
19. Inbaraj BS, Tsai T-Y, Chen B-H. Synthesis, characterization and antibacterial activity of superparamagnetic nanoparticles modified with glycol chitosan. Sci Tech Adv Mater. 2012;13:015002.
20. Shan Z, Yang W-S, Zhang X, Huang Q-M, Ye H. Preparation and characterization of carboxyl-group functionalized superparamagnetic nanoparticles and the potential for bio-applications. J Braz Chem Soc. 2007;18:1329-1335.
21. Inbaraj BS, Kao TH, Tsai TY, Chiu CP, Kumar R, Chen BH. The synthesis and characterization of poly (Y-glutamic acid)-coated magnetite nanoparticles and their effects on antibacterial activity and cytotoxicity. Nanotechnology. 2011;22:075101.
22. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010;28:580-588.
23. Daou TJ, Pourroy G, Begin-Colin S, et al. Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chem Mater. 2006;18: 4399-4404.
24. Peng X-H, Qian X, Mao H, et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine. 2008; 3:311-321.
25. 2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications. J Mater Chem. 2004;14:2781-2786.
26. Dong L, Yan L, Hou W-G, Liu S-J. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010;183:1811-1816.
27. Ho Y-S, Ofomaja AE. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. J Hazard Mater. 2006;129:137-142.
28. Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int J Pharm. 2013;4:21-26.
29. Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine. 2012;7:2767.
30. Matthews L, Kanwar RK, Zhou S, Punj V, Kanwar JR. Applications of nanomedicine in antibacterial medical therapeutics and diagnostics. The Open Tropical Medicine Journal. 2010;3:1-9.
31. Hajipour MJ, Fromm KM, Akbarashkarran A, et al. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012;30:497-554.
32. Hackenberg S, Scherzed A, Kessler M, et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett. 2011;201:27-33.
33. Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol. 2012;258:151-165.
34. Huh AJ, Kwon YJ. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156:128-145.
35. Yacoby I, Benhar I. Antibacterial nanomedicine. Nanomedicine. 2008;3:329-341.
36. Abeylath SC, Turos E, Dickey S, Lim DV. Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem. 2008;16:2412-2418.
37. Garay-Jimenez JC, Gergeres D, Young A, Lim DV, Turos E. Physical properties and biological activity of poly (butyl acrylate-styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants. Nanomedicine. 2009;5:443-451.
38. Turos E, Reddy G, Greenhalgh K, et al. Penicillin-bound polyacrylate nanoparticles: restoring the activity of β-lactam antibiotics against MRSA. Bioorg Med Chem Lett. 2007;17:3468-3472.